Join us at ESHG 2025 and learn how MGI commits in advancing clinical and population genomics
4/24/25
4/27/25
Offline
Milan, Italy
Share
MGI Corporate Session: Advancing Clinical and Population Genomics with MGI’s DNBSEQ and Multi-Omics Solutions
Join our must-attend session featuring real-world research in oncology and national genomics - showcasing how integrated approaches and DNBSEQ™ technology are advancing clinical genomics and personalized healthcare.
🕓 Saturday 24 May, 12:15 - 13:30 CET
📍 Room Amber 7 + 8
🍴 Lunch will be provided
REGISTER HERE
Agenda:
Building a National Genomic Infrastructure as Part of the European 1+ Million Genomes Initiative: Whole-Genome Sequencing for Population Reference and Clinical Applications. Prof. Janis Klovins, Professor & Head of the Scientific Council, Latvian Biomedical Research & Study Centre, Latvia
The Clinical Utility of Multigene Panel Analysis in Precision Oncology. Dr. Eirini Papadopoulou, International Laboratory Director, Genekor Medical S.A, Greece
Decode Half Million Genomes in Half Year: Insights from the China Kadoorie Biobank (CKB). Dr. Xin Jin, Chief Scientist & Director of the Institute of Precision Health Research at BGl-Research, China
Introducing Our Next Innovations
Live at Booth #310
Explore the DNBSEQ-T1+, DNBSEQ-G99, DNBSEQ-T7, DNBSEQ-T20x2 & Stereo-Seq spatial platforms - and speak with our experts to learn how our multi-omics solutions can advance your research.
Join us as we unveil the future of single-cell library prep - 24 May | 16:10 | Booth #310
Featured Talks and Posters at ESHG 2025
Unveiling spatial heterogeneity in medulloblastoma: a multi-omics analysis of cellular state and geographicalorganization. Dr. Li Jiankang, Session: C19-CancerComplexity: Variants,Therapies and AI-Driven Insights, Sunday, May 25
Artificial intelligence allows accurate fetal genome deduction and noninvasive prenatal diagnosis of single gene diseases and copy number variants in fetus. Dr. Ya Gao, Session: C21 - Prenatal and reproductive medicine, Sunday, May 25
Early prediction of preterm birth with cell-free RNA. Dr. Ji Yi, E-poster, at Exhibition Hall
Middle-read sequencing: bridging the gap between short-read and long-read sequencing with superior performance and cost efficiency. Dr. Heng Yi, E-poster, at Exhibition Hall
MGI Corporate Session: Advancing Clinical and Population Genomics with MGI’s DNBSEQ and Multi-Omics Solutions
Join our must-attend session featuring real-world research in oncology and national genomics - showcasing how integrated approaches and DNBSEQ™ technology are advancing clinical genomics and personalized healthcare.
🕓 Saturday 24 May, 12:15 - 13:30 CET
📍 Room Amber 7 + 8
🍴 Lunch will be provided
REGISTER HERE
Agenda:
Building a National Genomic Infrastructure as Part of the European 1+ Million Genomes Initiative: Whole-Genome Sequencing for Population Reference and Clinical Applications. Prof. Janis Klovins, Professor & Head of the Scientific Council, Latvian Biomedical Research & Study Centre, Latvia
The Clinical Utility of Multigene Panel Analysis in Precision Oncology. Dr. Eirini Papadopoulou, International Laboratory Director, Genekor Medical S.A, Greece
Decode Half Million Genomes in Half Year: Insights from the China Kadoorie Biobank (CKB). Dr. Xin Jin, Chief Scientist & Director of the Institute of Precision Health Research at BGl-Research, China
Introducing Our Next Innovations
Live at Booth #310
Explore the DNBSEQ-T1+, DNBSEQ-G99, DNBSEQ-T7, DNBSEQ-T20x2 & Stereo-Seq spatial platforms - and speak with our experts to learn how our multi-omics solutions can advance your research.
Join us as we unveil the future of single-cell library prep - 24 May | 16:10 | Booth #310
Featured Talks and Posters at ESHG 2025
Unveiling spatial heterogeneity in medulloblastoma: a multi-omics analysis of cellular state and geographicalorganization. Dr. Li Jiankang, Session: C19-CancerComplexity: Variants,Therapies and AI-Driven Insights, Sunday, May 25
Artificial intelligence allows accurate fetal genome deduction and noninvasive prenatal diagnosis of single gene diseases and copy number variants in fetus. Dr. Ya Gao, Session: C21 - Prenatal and reproductive medicine, Sunday, May 25
Early prediction of preterm birth with cell-free RNA. Dr. Ji Yi, E-poster, at Exhibition Hall
Middle-read sequencing: bridging the gap between short-read and long-read sequencing with superior performance and cost efficiency. Dr. Heng Yi, E-poster, at Exhibition Hall
MGI Corporate Session: Advancing Clinical and Population Genomics with MGI’s DNBSEQ and Multi-Omics Solutions
Join our must-attend session featuring real-world research in oncology and national genomics - showcasing how integrated approaches and DNBSEQ™ technology are advancing clinical genomics and personalized healthcare.
🕓 Saturday 24 May, 12:15 - 13:30 CET
📍 Room Amber 7 + 8
🍴 Lunch will be provided
REGISTER HERE
Agenda:
Building a National Genomic Infrastructure as Part of the European 1+ Million Genomes Initiative: Whole-Genome Sequencing for Population Reference and Clinical Applications. Prof. Janis Klovins, Professor & Head of the Scientific Council, Latvian Biomedical Research & Study Centre, Latvia
The Clinical Utility of Multigene Panel Analysis in Precision Oncology. Dr. Eirini Papadopoulou, International Laboratory Director, Genekor Medical S.A, Greece
Decode Half Million Genomes in Half Year: Insights from the China Kadoorie Biobank (CKB). Dr. Xin Jin, Chief Scientist & Director of the Institute of Precision Health Research at BGl-Research, China
Introducing Our Next Innovations
Live at Booth #310
Explore the DNBSEQ-T1+, DNBSEQ-G99, DNBSEQ-T7, DNBSEQ-T20x2 & Stereo-Seq spatial platforms - and speak with our experts to learn how our multi-omics solutions can advance your research.
Join us as we unveil the future of single-cell library prep - 24 May | 16:10 | Booth #310
Featured Talks and Posters at ESHG 2025
Unveiling spatial heterogeneity in medulloblastoma: a multi-omics analysis of cellular state and geographicalorganization. Dr. Li Jiankang, Session: C19-CancerComplexity: Variants,Therapies and AI-Driven Insights, Sunday, May 25
Artificial intelligence allows accurate fetal genome deduction and noninvasive prenatal diagnosis of single gene diseases and copy number variants in fetus. Dr. Ya Gao, Session: C21 - Prenatal and reproductive medicine, Sunday, May 25
Early prediction of preterm birth with cell-free RNA. Dr. Ji Yi, E-poster, at Exhibition Hall
Middle-read sequencing: bridging the gap between short-read and long-read sequencing with superior performance and cost efficiency. Dr. Heng Yi, E-poster, at Exhibition Hall
MGI Corporate Session: Advancing Clinical and Population Genomics with MGI’s DNBSEQ and Multi-Omics Solutions
Join our must-attend session featuring real-world research in oncology and national genomics - showcasing how integrated approaches and DNBSEQ™ technology are advancing clinical genomics and personalized healthcare.
🕓 Saturday 24 May, 12:15 - 13:30 CET
📍 Room Amber 7 + 8
🍴 Lunch will be provided
REGISTER HERE
Agenda:
Building a National Genomic Infrastructure as Part of the European 1+ Million Genomes Initiative: Whole-Genome Sequencing for Population Reference and Clinical Applications. Prof. Janis Klovins, Professor & Head of the Scientific Council, Latvian Biomedical Research & Study Centre, Latvia
The Clinical Utility of Multigene Panel Analysis in Precision Oncology. Dr. Eirini Papadopoulou, International Laboratory Director, Genekor Medical S.A, Greece
Decode Half Million Genomes in Half Year: Insights from the China Kadoorie Biobank (CKB). Dr. Xin Jin, Chief Scientist & Director of the Institute of Precision Health Research at BGl-Research, China
Introducing Our Next Innovations
Live at Booth #310
Explore the DNBSEQ-T1+, DNBSEQ-G99, DNBSEQ-T7, DNBSEQ-T20x2 & Stereo-Seq spatial platforms - and speak with our experts to learn how our multi-omics solutions can advance your research.
Join us as we unveil the future of single-cell library prep - 24 May | 16:10 | Booth #310
Featured Talks and Posters at ESHG 2025
Unveiling spatial heterogeneity in medulloblastoma: a multi-omics analysis of cellular state and geographicalorganization. Dr. Li Jiankang, Session: C19-CancerComplexity: Variants,Therapies and AI-Driven Insights, Sunday, May 25
Artificial intelligence allows accurate fetal genome deduction and noninvasive prenatal diagnosis of single gene diseases and copy number variants in fetus. Dr. Ya Gao, Session: C21 - Prenatal and reproductive medicine, Sunday, May 25
Early prediction of preterm birth with cell-free RNA. Dr. Ji Yi, E-poster, at Exhibition Hall
Middle-read sequencing: bridging the gap between short-read and long-read sequencing with superior performance and cost efficiency. Dr. Heng Yi, E-poster, at Exhibition Hall
Share this article :
Share
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).